Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome

By Yilmaz Murat   Bi˙ri˙ Aydan   Bukan Neslihan   Karakoç Ayhan   Sancak Banu   Törüner Füsun   Paşaoğlu Hatice  

Gynecological Endocrinology, Vol. 20, Iss. 5, 2005-05 ,pp. : 258-263

Informa Healthcare

Access to resources Recommend Favorite

Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome

By Chen Mei-Jou   Yang Wei-Shiung   Chen Hsin-Fu   Kuo Jahn-Jahn   Ho Hong-Nerng   Yang Yu-Shih   Chen Shee-Uan  

Human Reproduction, Vol. 25, Iss. 3, 2010-03 ,pp. : 779-785

Oxford University Press

Access to resources Recommend Favorite

Reproductive endocrinology. Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin

By Cibula D.  

Human Reproduction, Vol. 17, Iss. 1, 2002-01 ,pp. : 76-82

Oxford University Press

Access to resources Recommend Favorite

Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations

By Koo Young-Ah   Shin So-Young   Yoon Byung-Koo   Choi Dooseok  

Gynecological Endocrinology, Vol. 23, Iss. 8, 2007-08 ,pp. : 461-467

Informa Healthcare

Access to resources Recommend Favorite

Serum total l-carnitine levels in non-obese women with polycystic ovary syndrome

By Fenkci Semin Melahat   Fenkci Veysel   Oztekin Ozer   Rota Simin   Karagenc Nedim  

Human Reproduction, Vol. 23, Iss. 7, 2008-07 ,pp. : 1602-1606

Oxford University Press

Access to resources Recommend Favorite